New Treatment in Australia: A Potential Solution for Obesity Management ?
Australia is closely watching the arrival of retatrutide, a novel dual GIP and GLP-1 receptor agonist , representing a potential advance in weight loss . Early study data have demonstrated impressive results, showing greater efficacy than existing treatments like semaglutide. While yet to be form